CRISPR-based KCC2 upregulation attenuates drug-resistant seizure in mouse models of epilepsy. Shi J, Xin H, Shao Y, Dai S, et al. Ann Neurol 2023 Apr 4. doi: 10.1002/ana.26656.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shi J, Xin H, Shao Y, Dai S, et al. CRISPR-based KCC2 upregulation attenuates drug-resistant seizure in mouse models of epilepsy. Ann Neurol 2023 Apr 4. doi: 10.1002/ana.26656.
PMID: 37014252